Skip Navigation

watchlive

Pre-Markets
U.S. Markets
Currencies
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs

Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Industrials
Retail
Wealth
Sports
Life
Small Business

Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk

Cybersecurity
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide

White House
Policy
Defense
Congress
Equity and Opportunity

Live TV
Live Audio
Business Day Shows
Entertainment Shows
Full Episodes
Latest Video
Top Video
CEO Interviews
CNBC Documentaries
CNBC Podcasts
CNBC World
Digital Originals
Live TV Schedule

Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
Sign In

Pro News
Pro Live
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Sign In

Make It

USA
INTL

watchlive

These were the week's top performers, and Wall Street sees two of them rallying another 30%

Published Fri, Sep 2 20222:32 PM EDT

Michelle Fox @MFoxCNBC

This week's top performers managed to find gains amid the market downturn. All three major averages are on course to end the week lower , in what would be their third negative week in a row. Among the week's bright spots were two names that Wall Street believes has a lot more room to run. DXC Technology , was up 9.7% for the week through Thursday's close. The stock has 32.4% upside to the median analyst price target. Bath & Body Works , which has gained more than 4% week to date, has 31.4% upside, according to FactSet. What follows are companies that outperformed this week and where analysts stand on the stocks. To find these names, CNBC Pro looked for stocks in the space that had the best week-to-date performance. While DXC Technology and Bath & Body Works stand out as the names with the biggest potential upside, some other companies stand to have double-digit returns, according to the median analyst price target. Abbott Laboratories has 18.6% upside, with 56.5% of analysts covering the stock rating it a buy. The health-care company gained almost 3% this week through Thursday. Ulta Beauty , which reported better-than-expected results for its latest quarter last week, added just over 3% this week through Thursday. Raymond James named the retailer one of its top consumer staples picks . UBS also highlighted Ulta one of its high-conviction stocks that can outperform regardless of a slowdown. According to the median analyst price target, Ulta shares have 14.6% upside. Meanwhile, shares of Dollar General rose 2.7% this week through Thursday and have another 10.5% upside, according to the median analyst price target. Last week, the discount retailer raised its same-store sales guidance for the fiscal year. It's now above Wall Street's expectations.

Subscribe to CNBC PRO
Subscribe to Investing Club
Licensing & Reprints
CNBC Councils
Select Personal Finance
CNBC on Peacock
Join the CNBC Panel
Supply Chain Values
Select Shopping
Closed Captioning
Digital Products
News Releases
Internships
Corrections
About CNBC
Ad Choices
Site Map
Podcasts
Careers
Help
Contact

News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
Advertise With Us
Please Contact Us

Privacy Policy
CA Notice
Terms of Service

© 2024 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by